Oxybutynin Chloride 24 HR Oxybutynin chloride 10 MG Extended Release Oral Tablet
INDICATIONS AND USAGE Oxybutynin chloride extended-release tablets are a once-daily extended-release tablet indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin chloride extended-release tablets are also indicated in the treatment of pediatric patients aged 6 years and older with symptoms of detrusor overactivity associated with a neurological condition (e.g., spina bifida).
Aphena Pharma Solutions - Tennessee, Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Oxybutynin Chloride Extended-Release Tablets USP 5 mg are round, biconvex, white coated tablets imprinted in black ink with 270 on one side and K and U on the other side. They are supplied as follows: Bottles of 30 Tablets NDC 62175-270-32 Bottles of 100 Tablets NDC 62175-270-37 Bottles of 500 Tablets NDC 62175-270-41 Bottles of 1000 Tablets NDC 62175-270-43 Oxybutynin Chloride Extended-Release Tablets USP 10 mg are round, biconvex, white coated tablets imprinted in black ink with 271 on one side and K and U on the other side. They are supplied as follows: Bottles of 30 Tablets NDC 62175-271-32 Bottles of 100 Tablets NDC 62175-271-37 Bottles of 500 Tablets NDC 62175-271-41 Bottles of 1000 Tablets NDC 62175-271-43 Oxybutynin Chloride Extended-Release Tablets USP 15 mg are round, biconvex, white coated tablets imprinted in black ink with 272 on one side and K and U on the other side. They are supplied as follows: Bottles of 30 Tablets NDC 62175-272-32 Bottles of 100 Tablets NDC 62175-272-37 Bottles of 500 Tablets NDC 62175-272-41 Bottles of 1000 Tablets NDC 62175-272-43 Storage Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Protect from moisture and humidity.
More pills like ROUND KU 271